Your Music and People is a fantastic read full of great advice for creativity, business, and life in general. Insightful, funny and helpful for career musicians. I’m not a musician but this book is so much more than music. This should probably be called "Your Art and People" because there’s so much non-music stuff in here. Cheap renewables put so much economic pressure on traditional generation facilities that they may not be able to survive without subsidies. A good friend of mine taught a music business class for years. After reading it, I now keep it on my desk as a go-to reference book and creativity booster for thinking outside of the box about my music career. All readers, whatever level of wealth, will benefit from Sharp’s extensive knowledge and wisdom. Fire risk management Our Fire Risk Management Unit focuses on providing safe and secure buildings for all department-owned and operated facilities in Victoria. Worse still, the past two years have shaken the legal landscape for everyone involved. Musicians who feel lost on their career path would do well to read this book and internalize Derek’s advice. When we contact websites, they know we’re not just blowing smoke-we have the legal knowledge and resources to back up our demands.
articleextreme.comSRC:MixSentence, IDs:4F45A2FE;8E020393;430C4AF5;D7418648;029700BB;3AD5669B;CEC0943E;5E804A06;2C342F27;6B520626;EA73E075;F7F7F036;167CCA31;FEE5A7E4;AF24C528;07405E10;FDCAA27E;F1FE3AF6;F4EC029B;CC2BCDF5;49E5C53D;CE505E59;A29C6F39;103B5D06;878FED22;63624C40;03D22A85
"The time it takes for a new technology to be adopted by 50 percent of US households has long been used by economic historians for cross-technology comparisons. We would like to help draft this manuscript," Marcia Zabusky, a vice president of Intramed, told the doctors in a conference call, according to a transcript of the conversation obtained by The New York Times, "and then submit it to you for your - for your editing and for approval." During the call, Shane Schaffer, a Novartis marketing executive, told the doctors that the company wanted "a quick, down and dirty" article. Markowitz and Kennerly S. "Obviously, we have to stick within data limits of what's published currently as well as what we know are factual about these products," he told the doctors. Patrick of the Medical University of South Carolina - agreed to what Intramed and Novartis proposed. Patrick said as the call concluded. "But, of course, inferences can be made." One such "potential theoretical conclusion" of the article, Ms. For those who have virtually any concerns relating to where by and the best way to employ legal services, you can e-mail us at our internet site. A study expected to provide scientific data showing Ritalin LA's advantages was not scheduled to start until the following day, he said, but the lack of research findings should not be an obstacle. Starting with an outline approved by Intramed, Dr. To produce the new draft, Intramed turned to Linda Logdberg, who has a doctorate in anatomy and has made her living the last 12 years as a ghostwriter for Intramed and other medical marketing companies. "I think we're quite clear on what you want the next manuscript to look like," Dr. Zabusky added, was that a drug that worked for 9 hours might be better than a 12-hour drug. Logdberg said that she produced a new manuscript in a few days. Some doctors fretted over each comma, Dr. The marketing companies, she added, "will drop a doctor if they don't think he will be particularly malleable." The result, Dr. Logdberg said, is marketing masquerading as science. Logdberg, who recently took a job teaching biology to high school students, said that she had become increasingly disenchanted with the process. "What I mind is advertising that calls itself education." The ad agencies' medical education companies say that they neither toy with science nor ghostwrite articles that physicians use to make decisions about prescribing drugs. "We make editorial suggestions," said Jed A. Beitler, chairman of Sudler & Hennessey, a division at WPP that includes Intramed. The assignment was one of her last ghostwriting tasks. Logdberg said, while others made no changes at all. "The doctors are the ultimate writers." Dr. Neither the doctors nor the companies disputed the accuracy of the transcript of their conference call. Patrick added that he thought, based on past research, that a drug like Ritalin LA could be better for certain children than other long-lasting drugs. "No figure, no table, anything goes in without our approval," Dr. Novartis said the article was not intended to conclude that one product was better than the others. Typically, she said, her manuscript would be sent to the drug company for approval before it was given to the doctors who were paid to be listed as the authors. The article has not been published. Beitler said that Intramed was unhappy with the manuscript that Dr. A 1998 survey of named authors writing for some of the nation's top journals, including The Journal of the American Medical Association, which published the survey, found that 11 percent of the articles had been ghostwritten. Patrick agreed, saying that Intramed did not dictate what their paper should say. Evidence of ghostwriting has also surfaced in federal and state investigations of Warner-Lambert's marketing of Neurontin, an epilepsy drug, for more than a dozen unapproved uses. Logdberg produced and later gave the assignment to another writer. Proworx planned to recruit doctors to be the named authors of the articles, paying them a $1,500 fee. Some experts think the practice continues to grow, even as the best journals take steps to prevent it. Instead, the company said, it was a review of the available medications in which the authors could suggest theoretical advantages. Relman, the former editor of The New England Journal of Medicine, said there was no place in medical education for ad agencies. Wyeth hired ghostwriters in promoting the diet drug combination fen-phen, according to documents made public in litigation filed after it became evident that fen-phen caused a potentially deadly heart-valve defect. One document made public in a whistle-blower lawsuit against Warner-Lambert describes how Proworx, a company owned by the ad giant Omnicom, offered to help write journal articles about using Neurontin to treat pain. "That's the coin of the realm. "We don't get anywhere in medicine without objective data," he said. Omnicom declined to comment on the matter.